Plain-English translation of NCT07782268 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a therapy called Written Exposure Therapy (WET) for people who have both post-traumatic stress disorder (PTSD) and substance use disorder. The study will enroll 400 people already in a 28-day residential treatment program. Half will receive the standard care plus five one-hour therapy sessions focused on writing about their traumatic experience, while the other half will receive standard care alone.
Many people struggling with addiction also have unhealed trauma from past experiences, and treating both conditions together may help them recover better. This study wants to see if adding this writing-based therapy to standard residential treatment can reduce trauma symptoms and improve overall recovery outcomes.
If you join this study, you'll continue with your regular residential treatment program. If randomly selected for the therapy group, you'll have five individual sessions with a therapist where you'll write about your traumatic experience — each session takes less than an hour. Researchers will measure your PTSD symptoms, substance use progress, and mental health before and after the treatment period to see if the writing therapy helps.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
United States